Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision changed from v3.4.2 to v3.4.3 in the Record History. No study content or user actions are affected.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA new site revision entry 'Revision: v3.4.2' was added to the history, and the notices for government funding lapse and the previous 'Revision: v3.4.1' were removed from deletions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedSite-wide notices about government funding and operating status were added, along with a site version update to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedIntroduces a Show glossary option and color-coded change legends for additions and deletions, with an updated revision badge to v3.4.0. The No FEAR Act data wording is updated between versions.SummaryDifference0.9%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added to the Records History and the previous v3.3.3 entry was removed, reflecting a minor update to the page’s history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. This is a minor administrative update that does not affect the study data or page content.SummaryDifference0.2%

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.